(Dose Response[TA])
1,345 results
  • Low-Dose Radiation-Induced Expression of Exosomal miRNAs in the Serum of Medical Radiation Workers. [Journal Article]
    Dose Response. 2026 Jul-Sep; 24(3):15593258261488713.Wang P, Wei L, … Lyu YDR
  • Objective: Long-term low-dose ionizing radiation may alter genomes and cause diseases. This study examined serum exosomal miRNA differences among radiation-exposed medical workers by work types. Methods: High-throughput sequencing screened serum exosomal miRNAs in diagnostic radiologists, interventional radiologists, and nuclear medicine doctors. qRT-PCR validated differentially expressed miRNAs.…
  • Research Progress on Dietary Intervention in Radiation Protection. [Review]
    Dose Response. 2026 Jul-Sep; 24(3):15593258261487097.Du J, Ding X, … Lu LDR
  • The application of nuclear technology in energy, healthcare, and aerospace sectors is increasingly widespread, causing radiation protection to be an important topic for public health and biomedical research. Ionizing radiation causes harm by damaging cells directly or indirectly. Traditional radiation protection adopts physical barriers and pharmacological methods, which have proved to be effecti…
  • The LNT Model and ALARA in Diagnostic Imaging: A Critical Review of Scientific Evidence in the Low-Dose Range. [Review]
    Dose Response. 2026 Jul-Sep; 24(3):15593258261481921.Soliman K, Alhazmi ADR
  • CONCLUSIONS: Within the LDDR range, the available evidence does not support a linear dose-response relationship, and the indiscriminate application of ALARA based on hypothetical risks may produce net harm through deferred imaging, radiophobia, and inefficient resource allocation. We propose that radiation protection in medical imaging shift toward an evidence-informed framework that prioritizes image quality optimization, individualized risk assessment, and the adoption of complementary principles such as ASARA (As Safe As Reasonably Achievable) and AHARA (As High As Reasonably Achievable benefits). A linear-with-threshold (LT) model and the adverse outcome pathway (AOP) framework warrant further investigation as alternatives to LNT for regulatory purposes.